Tabrecta

{
  "id": "MLC-T-ONC-008481",
  "term": "Tabrecta",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with non-small cell lung cancer that has spread and has a certain mutation (change) in the MET gene. It is also being studied in the treatment of other types of cancer. Tabrecta blocks a protein made by the MET gene, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called capmatinib hydrochloride.",
  "synonyms": [
    "capmatinib hydrochloride"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tabrecta/"
}